|
Original Article
Prognostic analysis according to adjuvant chemotherapy and anti-HER2 therapy following surgery in T1a/b HER2-positive breast cancer
Woochan Park, Koung Jin Suh, Jeongmin Seo, Se Hyun Kim, Yu Jung Kim, Hee-Chul Shin, Eun-Kyu Kim, In Ah Kim, So Yeon Park, Jee Hyun Kim
Korean J Intern Med. 2026;41(4):734-747. Published online July 1, 2026
Background/Aims: The optimal adjuvant chemotherapy and anti-human epidermal growth factor receptor 2 (HER2) therapy regimen following surgery for T1a/b HER2-positive breast cancer remains debatable.
Methods: In this single-center retrospective analysis, we examined the postoperative treatment strat..
|